Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares Outstanding
Ratios

Phibro Animal Health (PAHC) Shares Issued (2016 - 2019)

Phibro Animal Health has reported Shares Issued over the past 5 years, most recently at $793000.0 for Q1 2019.

  • For Q1 2019, Shares Issued fell 50.19% year-over-year to $793000.0; the TTM value through Jun 2019 reached $1.1 million, down 80.1%, while the annual FY2019 figure was $1.1 million, 80.1% down from the prior year.
  • Shares Issued for Q1 2019 was $793000.0 at Phibro Animal Health, up from $130000.0 in the prior quarter.
  • Over five years, Shares Issued peaked at $3.5 million in Q3 2017 and troughed at $52000.0 in Q2 2016.
  • A 5-year average of $1.2 million and a median of $718000.0 in 2015 define the central range for Shares Issued.
  • Biggest five-year swings in Shares Issued: surged 5594.23% in 2017 and later plummeted 93.95% in 2018.
  • Year by year, Shares Issued stood at $1.4 million in 2015, then tumbled by 96.25% to $52000.0 in 2016, then surged by 311.54% to $214000.0 in 2017, then plummeted by 39.25% to $130000.0 in 2018, then skyrocketed by 510.0% to $793000.0 in 2019.
  • Business Quant data shows Shares Issued for PAHC at $793000.0 in Q1 2019, $130000.0 in Q4 2018, and $211000.0 in Q3 2018.